Redox Grabs $45M Series D Funding

The round was led by global private equity firm Adams Street Partners, with participation from Avenir and existing investors Battery Ventures, .406 Ventures, and RRE Ventures.

Redox's funding to date tops $95 million. The company will apply the current investments to accelerate product innovation, hire new talent, and meet widespread demand for its health data integration platform.

Redox accelerates the development and distribution of healthcare software solutions with a full-service integration platform to securely and efficiently exchange healthcare data. With just one connection, data can be transmitted across a growing network of over 1,400 healthcare delivery organizations and 350 independent software vendors. Members of the Redox Network exchange more than 12 million patient records per day, leveraging a single data standard compatible with more than 55 electronic health record systems. Redox exists to make healthcare data useful and every patient's experience a little bit better. Learn how you can leverage the Redox Platform at www.redoxengine.com.